These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33611708)
1. Convection-enhanced drug delivery for glioblastoma: a review. D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708 [TBL] [Abstract][Full Text] [Related]
2. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics. Ung TH; Malone H; Canoll P; Bruce JN CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989 [TBL] [Abstract][Full Text] [Related]
3. Convection-enhanced delivery for the treatment of glioblastoma. Vogelbaum MA; Aghi MK Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
5. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts. Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491 [TBL] [Abstract][Full Text] [Related]
6. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma. Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643 [TBL] [Abstract][Full Text] [Related]
7. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies. Jahangiri A; Chin AT; Flanigan PM; Chen R; Bankiewicz K; Aghi MK J Neurosurg; 2017 Jan; 126(1):191-200. PubMed ID: 27035164 [TBL] [Abstract][Full Text] [Related]
8. Imaging of convection enhanced delivery of toxins in humans. Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706 [TBL] [Abstract][Full Text] [Related]
9. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas. Saito R; Tominaga T Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285 [TBL] [Abstract][Full Text] [Related]
10. Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept. Halle B; Marcusson EG; Aaberg-Jessen C; Jensen SS; Meyer M; Schulz MK; Andersen C; Kristensen BW J Neurooncol; 2016 Jan; 126(1):47-55. PubMed ID: 26428358 [TBL] [Abstract][Full Text] [Related]
11. Convection enhanced delivery for the treatment of malignant gliomas: symposium review. Vogelbaum MA J Neurooncol; 2005 May; 73(1):57-69. PubMed ID: 15933820 [TBL] [Abstract][Full Text] [Related]
12. Liposomal temozolomide drug delivery using convection enhanced delivery. Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727 [TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced delivery: from mechanisms to clinical drug delivery for diseases of the central nervous system. Saito R; Tominaga T Neurol Med Chir (Tokyo); 2012; 52(8):531-8. PubMed ID: 22976134 [TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced Drug Delivery for Glioblastoma: A Systematic Review Focused on Methodological Differences in the Use of the Convection-enhanced Delivery Method. Halle B; Mongelard K; Poulsen FR Asian J Neurosurg; 2019; 14(1):5-14. PubMed ID: 30937002 [TBL] [Abstract][Full Text] [Related]
15. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761 [TBL] [Abstract][Full Text] [Related]
16. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme. White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. Degen JW; Walbridge S; Vortmeyer AO; Oldfield EH; Lonser RR J Neurosurg; 2003 Nov; 99(5):893-8. PubMed ID: 14609170 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant convection-enhanced delivery for the treatment of brain tumors. Kreatsoulas D; Damante M; Cua S; Lonser RR J Neurooncol; 2024 Jan; 166(2):243-255. PubMed ID: 38261143 [TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851 [TBL] [Abstract][Full Text] [Related]
20. Convection and retro-convection enhanced delivery: some theoretical considerations related to drug targeting. Motion JP; Huynh GH; Szoka FC; Siegel RA Pharm Res; 2011 Mar; 28(3):472-9. PubMed ID: 20963628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]